Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Bruker
BRKR
$8.78B
| $46.6M | 0.02% |
597,180
-262,219
| -31% | -$21.8M |
|
927
Wyndham Hotels & Resorts
WH
$5.47B
| $46.6M | 0.02% |
604,096
+25,779
| +4% | +$1.85M |
|
928
Hawaiian Electric Industries
HE
$2.08B
| $46.4M | 0.02% |
1,135,641
+41,044
| +4% | +$1.76M |
|
929
Ultragenyx Pharmaceutical
RARE
$2.64B
| $46.3M | 0.02% |
513,849
+16,748
| +3% | +$1.51M |
|
|
PLAN
930
DELISTED
Anaplan, Inc.
PLAN
| $46.3M | 0.02% |
760,262
+24,885
| +3% | +$1.48M |
|
931
Sabra Healthcare REIT
SBRA
$5.16B
| $46.3M | 0.02% |
3,142,581
+205,496
| +7% | +$3.47M |
|
932
Inspire Medical Systems
INSP
$1.68B
| $46.2M | 0.02% |
198,484
+2,023
| +1% | +$422K |
|
933
iShares Core S&P US Growth ETF
IUSG
$33.7B
| $46.2M | 0.02% |
+451,080
| New | +$47.6M |
|
934
RenaissanceRe
RNR
$13.3B
| $46.2M | 0.02% |
331,219
+4,887
| +1% | +$740K |
|
|
SKX
935
DELISTED
Skechers
SKX
| $46.2M | 0.02% |
1,096,043
+26,314
| +2% | +$1.3M |
|
936
Fate Therapeutics
FATE
$321M
| $46.1M | 0.02% |
777,327
+194,189
| +33% | +$15.2M |
|
937
Rapid7
RPD
$855M
| $46.1M | 0.02% |
407,544
+7,011
| +2% | +$794K |
|
938
BlackLine
BL
$1.64B
| $46M | 0.02% |
389,422
+10,608
| +3% | +$1.22M |
|
939
Woodward
WWD
$21.3B
| $45.8M | 0.02% |
404,825
+35,047
| +9% | +$4.16M |
|
940
Mine Safety
MSA
$7.4B
| $45.8M | 0.02% |
314,454
+10,268
| +3% | +$1.63M |
|
|
HBI
941
DELISTED
Hanesbrands
HBI
| $45.7M | 0.01% |
2,661,360
+78,420
| +3% | +$1.47M |
|
942
Sensata Technologies
ST
$6.71B
| $45.6M | 0.01% |
834,133
+27,084
| +3% | +$1.56M |
|
943
Zillow
Z
$7.37B
| $45.5M | 0.01% |
516,580
+40,903
| +9% | +$4.14M |
|
944
Macerich
MAC
$6.95B
| $45.5M | 0.01% |
2,722,647
+459,378
| +20% | +$7.8M |
|
945
Commerce Bancshares
CBSH
$8.5B
| $45.5M | 0.01% |
833,245
+38,239
| +5% | +$2.11M |
|
|
WCC
946
WESCO International
WCC
$18B
| $45.5M | 0.01% |
394,161
-3,574
| -0.9% | -$394K |
|
947
EPR Properties
EPR
$4.65B
| $45.3M | 0.01% |
918,087
+24,261
| +3% | +$1.23M |
|
948
Graphic Packaging
GPK
$3.49B
| $45.2M | 0.01% |
2,375,685
+46,812
| +2% | +$892K |
|
949
Portland General Electric
POR
$5.75B
| $45.1M | 0.01% |
960,384
+16,355
| +2% | +$805K |
|
|
UNIT
950
Uniti Group
UNIT
$2.31B
| $45.1M | 0.01% |
3,646,621
+79,817
| +2% | +$973K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.